# Study of DU-176b Aged 80 Years or Older

Study · id `cardio:ct-nct02801669` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02801669](<https://clinicaltrials.gov/study/NCT02801669>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02801669

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 984 participants.

## Technical summary

Registry record NCT02801669. Randomized; triple masking; primary purpose prevention. Start 2016-08-05 (actual); primary completion 2019-12-27 (actual). Results posted on 2020-11-19.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 984 participants (enrolled count; ClinicalTrials.gov record NCT02801669, source copy `cardio:ctgov-nct02801669-2020-11-19`, retrieved 2026-10-26)
- Started: 2016-08-05 (actual) (ClinicalTrials.gov record NCT02801669, source copy `cardio:ctgov-nct02801669-2020-11-19`, retrieved 2026-10-26)
- Primary completion: 2019-12-27 (actual) (ClinicalTrials.gov record NCT02801669, source copy `cardio:ctgov-nct02801669-2020-11-19`, retrieved 2026-10-26)
- Completion: 2019-12-27 (actual) (ClinicalTrials.gov record NCT02801669, source copy `cardio:ctgov-nct02801669-2020-11-19`, retrieved 2026-10-26)
- Results first posted: 2020-11-19 (ClinicalTrials.gov record NCT02801669, source copy `cardio:ctgov-nct02801669-2020-11-19`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT02801669, source copy `cardio:ctgov-nct02801669-2020-11-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02801669-2020-11-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of DU-176b Aged 80 Years or Older
- Condition: Atrial Fibrillation
- Intervention (Drug): Du-176b
- Intervention (Drug): placebo
- Lead sponsor: Daiichi Sankyo Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Daiichi Sankyo Co., Ltd. (`cardio:org-daiichi-sankyo-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation (`cardio:pubmed-32865374`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation: A Prespecified Subanalysis of the ELDERCARE-AF Randomized Clinical Trial (`cardio:pubmed-35416910`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Laboratory Test Predictors for Major Bleeding in Elderly (≥80 Years) Patients With Nonvalvular Atrial Fibrillation Treated With Edoxaban 15 mg: Sub-Analysis of the ELDERCARE-AF Trial (`cardio:pubmed-36056729`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and Safety of Low-Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE-AF Trial (`cardio:pubmed-38240204`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: cf8b7f7497931850c899c5e64f218fa589fa4aaf40fcccbbc02ca9bbffc4ce0b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
